See what’s changing first. Know which accounts matter next.
Fundz catches funding rounds before they’re announced, and acquisitions, new executives, hiring shifts and contract wins as they happen. It weighs them against your ideal customer profile and delivers a ranked shortlist every morning, with the evidence, the reason to reach out and the decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
One Biosciences secures €3.3M in non-dilutive public funding from Bpifrance to advance its single-cell precision oncology platform and support clinical translation.
Amount Raised
€3.3 Million
Round Type
Seed
SacramentoBiotechnologyInvestors
Description
One Biosciences, a Paris-based techbio startup, received €3.3M in non-dilutive public funding awarded by Bpifrance under the i-Démo 5 project call as part of France 2030 initiative. The grant will finance the CAST project, a four-year clinical translation program in collaboration with Institut Curie. Funds will be used to industrialize the company's molecular profiling platform, validate predictive biomarkers, prepare for CE-IVD regulatory approvals, and scale clinical laboratory infrastructure. One Biosciences develops OneMap™, a single-cell transcriptomics platform designed to guide personalized oncology treatment for Triple-Negative Breast Cancer.
Fundz sees it the moment One Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
One Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.